Beam stock forecast.

Beam Price Live Data. The live Beam price today is $0.164128 USD with a 24-hour trading volume of $6,003,743 USD. We update our BEAM to USD price in real-time. Beam is up 214.10% in the last 24 hours. The current CoinMarketCap ranking is #654, with a live market cap of $24,315,976 USD. It has a circulating supply of 148,152,520 BEAM coins and a ...Nov 18, 2023 · Future criteria checks 1/6. Beam Therapeutics's earnings are forecast to decline at 11.2% per annum while its annual revenue is expected to grow at 12.2% per year. EPS is expected to decline by 3.5% per annum. Return on equity is forecast to be -82.9% in 3 years. When planning outdoor activities or making travel arrangements, having access to accurate weather forecasts is crucial. One commonly used tool is the 7 day weather forecast, which provides an outlook for the upcoming week.According to the issued ratings of 11 analysts in the last year, the consensus rating for Beam Therapeutics stock is Hold based on the current 6 hold ratings and 5 buy ratings for BEAM. The average twelve-month price prediction for Beam Therapeutics is $48.80 with a high price target of $105.00 and a low price target of $20.00. Learn more on ...

Beam Therapeutics Inc. (BEAM) share price prediction for 2023, 2024, 2025, 2026 and 2027. BEAM one year forecast. Beam Therapeutics stock monthly and weekly forecasts.View the latest Verizon Communications Inc. (VZ) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Mar 5, 2023 · Following the upgrade, the consensus from 13 analysts covering Beam Therapeutics is for revenues of US$60m in 2023, implying a small 2.2% decline in sales compared to the last 12 months. Per-share ... According to 9 stock analysts, the average 12-month stock price forecast for BEAM stock stock is $55.22, which predicts an increase of 93.14%. The lowest target is $32 and the highest is $105. On average, analysts rate BEAM stock stock as a buy. Analyst Consensus: Buy * Price targets were last updated on Oct 17, 2023. Analyst Ratings

Find real-time ROKU - Roku Inc stock quotes, company profile, news and forecasts from CNN Business.Vroom, Inc. (NASDAQ:VRM) posted its earnings results on Tuesday, November, 7th. The company reported ($0.59) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.41) by $0.18. The company earned $235.63 million during the quarter, compared to analyst estimates of $223.90 million.Stock Price Forecast The 12 analysts offering 12-month price forecasts for Pacific Biosciences of California Inc have a median target of 10.50, with a high estimate of 19.00 and a low estimate of ...Beam Therapeutics Inc Stock Price History. Beam Therapeutics Inc’s price is currently down 1.73% so far this month. During the month of April, Beam Therapeutics Inc’s stock price has reached a high of $32.82 and a low of $28.62. Over the last year, Beam Therapeutics Inc has hit prices as high as $73.27 and as low as $27.77. Year to date ...View Beam Global BEEM investment & stock information. Get the latest Beam Global BEEM detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

Find real-time DNA - Ginkgo Bioworks Holdings Inc stock quotes, company profile, ... EPS forecast (this quarter)-$0.07: Annual revenue (last year) $477.7M: Annual profit (last year)

Find real-time MELI - MercadoLibre Inc stock quotes, company profile, news and forecasts from CNN Business.

According to 4 analyst offering 12-month price targets in the last 3 months, Beam Therapeutics has an average price target of $70.25 with a high of $105.00 and a low of $37.00. Below is a summary ...Most industries use structural steel beams to build their structures due to their strength, ease of construction and durability. The cost of structural steel beams varies depending on their size and shape.Sector. Producer Manufacturing. Industry. Industrial Machinery. No executives to display. Corporate headquarters. --, --. Find real-time VLD - Velo3D Inc stock quotes, company profile, news and ...Dec 1, 2023 · John Evans. Beam Therapeutics Inc., a biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious diseases in the United States. It develops BEAM-101 and BEAM-102 for the treatment of sickle cell disease beta thalassemia; BEAM-201, an allogeneic chimeric antigen receptor T cell for the ... It’s difficult to put a positive spin on the current state of the stock market. While 2022’s action has seen moments of relief, for the most part, the trend has been resolutely downbeat, as reflected in the main indexes’ performances. All are down by at least double-digits; the tech-heavy NASDAQ’s 27% drop has been the most acute, while the …Earnings vs Market: BEEM is forecast to become profitable over the next 3 years, which is considered above average market growth. High Growth Earnings: BEEM is expected to become profitable in the next 3 years. Revenue vs Market: BEEM's revenue (24.5% per year) is forecast to grow faster than the US market (7.7% per year).

Oct 20, 2023 · According to the issued ratings of 11 analysts in the last year, the consensus rating for Beam Therapeutics stock is Hold based on the current 6 hold ratings and 5 buy ratings for BEAM. The average twelve-month price prediction for Beam Therapeutics is $53.64 with a high price target of $105.00 and a low price target of $20.00. According to 4 analyst offering 12-month price targets in the last 3 months, Beam Therapeutics has an average price target of $70.25 with a high of $105.00 and a low of $37.00. Below is a summary ...Next reporting date. February 13, 2024. EPS forecast (this quarter) -$0.20. Annual revenue (last year) $185.3M. Annual profit (last year) -$200.2M. Net profit margin.Technology Services. Industry. Packaged Software. No executives to display. Corporate headquarters. --, --. Find real-time PLTR - Palantir Technologies Inc stock quotes, company profile, news and ...Beam Global analyst ratings, historical stock prices, earnings estimates & actuals. BEEM updated stock price target summary.Nov 29, 2023 · According to 3 analysts, the average rating for BEEM stock is "Strong Buy." The 12-month stock price forecast is $26.67, which is an increase of 343.02% from the latest price.

Global whiskey market: leading brands based on sales volume 2022. In 2022, some 30.8 million 9 liter cases of McDowell's No. 1 whiskey were sold worldwide. Royal Stag was number two that year ...

Beam Therapeutics Stock Forecast Over the next 52 weeks, Beam Therapeutics has on average historically fallen by 0.2% based on the past 3 years of stock performance. Beam Therapeutics has fallen lower in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%Market outlook and 2024-2025 steel price forecasts. Taken together, MCI's judgement regarding the current level of steel prices in the context of the longer-term price cycle; with our assessment of expected changes to the steel supply demand balance in 2024; and our review of the near-term outlook for iron ore and coke prices – all point to a ...Find real-time EDIT - Editas Medicine Inc stock quotes, company profile, news and forecasts from CNN Business.“This call aims to develop an USPL that is ruggedized enough to begin testing in relevant Army environments,” it continued. The Army also began testing a prototype laser weapon for close-range air defense in May, the Defense Post reported.The high-energy laser will be able to locate, lock on, track and destroy aerial threats in just seconds.REINHARDT KRAUSE. 12:05 PM ET 10/25/2023. The best 5G stocks will evolve over time as business services delivered via cloud computing add new opportunities for wireless firms. But the 5G ...Chronic organ damage is the leading cause of death in adults with SCD. Beam is advancing multiple base editing programs for sickle cell disease, led by Beam-101, an ex vivo cell therapy in which cells are collected from a patient, edited, and then infused back into the patient. To create space for the edited cells to take hold in the bone ...

Stock Price Forecast. The 20 analysts offering 12-month price forecasts for Nintendo Co Ltd have a median target of 46.72, with a high estimate of 59.00 and a low estimate of 31.78. The median ...

14,305.03 +78.81(+0.55%) Russell 2000 1,862.64 +53.62(+2.96%) Crude Oil 74.38 -1.58(-2.08%) Gold 2,091.70 +34.50(+1.68%) Beam Therapeutics Inc. (BEAM) NasdaqGS - NasdaqGS Real Time Price....

BEEM stock forecast for 2023 – 2027. Last updated: November 25, 2023. BEEM. Beam Global. 5.85 D 4.84% (0.27) Are you interested in Beam Global stocks prediction? If yes, then on this page you will find useful information about the dynamics of the BEEM stock price in 2022-2027. Is BEEM a good long term stock? When should I …Mar 5, 2023 · Following the upgrade, the consensus from 13 analysts covering Beam Therapeutics is for revenues of US$60m in 2023, implying a small 2.2% decline in sales compared to the last 12 months. Per-share ... This is hardly the only bullish review for Beam, although the company’s 6 recent analyst reviews do have an even split between Buys and Holds – making the consensus rating a Moderate Buy. BEEM shares have an average target of $29.50 and a current trading price of $15.09, suggesting ~95% upside going forward. (See BEAM stock forecast on ...This is where a guiding hand from Wall Street’s pros comes in handy. The stock experts at banking giant Wells Fargo have identified two names whose share price is down over 50% this year ...The average stock forecast for Beam Therapeutics Inc (BEAM) is 54.77 USD. This price target corresponds to an upside of 85.21%. The range of stock …Well, it was only a matter of time. Advertising giant Facebook announced Wednesday that they’re going to begin testing advertising inside virtual reality titles on its Oculus platform soon. The first roll-out is limited enough, with Faceboo...Future criteria checks 2/6. CRISPR Therapeutics is forecast to grow earnings and revenue by 46.4% and 48.2% per annum respectively. EPS is expected to grow by 45.6% per annum. Return on equity is forecast to be 2% in 3 years.BEKE one year forecast. KE Holdings stock monthly and weekly forecasts. Skip to content. FORECST.COM 2023 – 2026 Stock Market Forecast BEKE stock forecast for 2023 – 2027. Last updated: October 26, 2023. Are you interested in KE Holdings Inc. stocks prediction? ... BEAM Stock Forecast; BE Stock Forecast;

The first Wood-backed stock we’ll look at is Beam Therapeutics, ... Going by the $70.89 average target, the shares will climb ~62% higher in the year ahead. (See BEAM stock forecast)Feb 1, 2023 · (See BEAM stock forecast) CareDx, Inc . The next Wood-endorsed stock also belongs in the healthcare sector, although it offers a different value proposition. CareDx is a commercial-stage ... The Beam Therapeutics stock forecast for tomorrow is $ 27.79, which would represent a -6.02% loss compared to the current price. In the next week, the price of BEAM is expected to decrease by -2.93% and hit $ 28.70. As far as the long-term Beam Therapeutics stock forecast is concerned, here’s what our predictions are currently suggesting.Instagram:https://instagram. 52 week high stocka mark metalschiropractor cost no insurance1847 holdings dividend Beam Global Stock Price, News & Analysis (NASDAQ:BEEM) $6.02 -0.12 (-1.95%) (As of 11/29/2023 ET) Compare Today's Range $6.01 $6.57 50-Day Range $5.35 …About the Beam Global stock forecast. As of 2023 November 26, Sunday current price of BEEM stock is 5.850$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).. Beam Global stock price has been showing a declining tendency so we believe that similar market segments were not very popular in … best crypto bot trading platformallstate dog insurance BEAM : Suntory Holdings Completes Acquisition of Beam Inc. 2014: BU BEAM : Jim Beam To Host "Distillery Days" In Clermont 2014: PR Beam : Announces Intention to Delist and Deregister Common Stock, 8 5/8% Debentures Due 2021 and 7 … large growth stocks 7 brokers have issued 12-month price objectives for Sangamo Therapeutics' shares. Their SGMO share price targets range from $1.00 to $10.00. On average, they expect the company's stock price to reach $4.68 in the next twelve months. This suggests a possible upside of 1,150.3% from the stock's current price. View analysts price targets …According to 9 stock analysts, the average 12-month stock price forecast for BEAM stock stock is $55.22, which predicts an increase of 93.14%. The lowest …BEAM - Beam Therapeutics Inc Stock - Stock Price, Institutional Ownership, Shareholders (NASDAQ)